Foundation Medicine Revenue, Profits - FMI Quarterly Income Statement

Add to My Stocks
$80.8 $0.95 (1.19%) FMI stock closing price Mar 19, 2018 (Closing)

FMI stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Foundation Medicine stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Like any other income statement, the FMI income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 21.89% when compared to the same period in the past. The operating expenses as shown in the Foundation Medicine profit and loss statement for 2017 Q3 total to $55.94M. This line item shows that the operating expenses has decreased compared with last year. Also check: Foundation Medicine assets and Foundation Medicine free cash flow.

View and download details of revenue and profits for Foundation Medicine for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Foundation Medicine Revenues or Net Sales
Cost Of Goods Sold (COGS)19.12M21.58M18.01M17.46M15.94M11.95M11.39M11.2M10.37M
Foundation Medicine Gross Profit
Research & Development Expense22.39M22.97M23.28M18.19M17.23M18.5M13.45M12.78M12.17M
Selling General & Admin Expense33.55M34.76M31.71M28.91M27.66M26.98M23.01M21.21M23.46M
Income Before Depreciation Depletion Amortization-32.42M-44.31M-46.68M-35.71M-31.42M-29.2M-17.48M-19.12M-20.61M
Depreciation Depletion Amortization---------
Non Operating Income-0.21M-------0.03M-
Interest Expense----0.05M----0.12M-
Foundation Medicine Pretax Income
Provision for Income Taxes---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-32.64M-44.26M-46.45M-35.61M-31.28M-28.99M-17.31M-19.02M-20.6M
Extraordinary Items & Discontinued Operations---------
Foundation Medicine Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS36.09M35.66M35.43M35.07M34.95M34.61M34.54M34.45M34.35M
Average Shares used to compute Basic EPS36.09M35.66M35.43M35.07M34.95M34.61M34.54M34.45M34.35M
Income Before Nonrecurring Items-32.64M-44.26M-46.45M-35.61M-31.28M-28.99M-17.31M-19.02M-20.6M
Income from Nonrecurring Items---------
Foundation Medicine Earnings Per Share Basic Net
Foundation Medicine Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.90-1.24-1.31-1.02-0.90-0.84-0.50-0.55-0.60
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Foundation Medicine stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that FMI stock has a topline or revenue of $42.66M for 2017 Q3 as per this Foundation Medicine revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-32.64M for FMI stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The FMI financials along with Foundation Medicine historical stock prices provide a lot of details about the firm.

Foundation Medicine Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield

Other Income Statements - Foundation Medicine Inc Industry Peers

Athenahealth income statement, Illumina income statement, Medidata income statement, OncoCyte income statement